JOHNSON & JOHNSON (JNJ)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter JOHNSON & JOHNSON has filed, from EvidInvest's standardized statements.
Period end
Jun 30, 2026
Q2 FY2026
Filed
Jun 30, 2026
Filing date on record
EPS (diluted)
$2.27
Est. $2.84 · -20.1%
Revenue
$25.31B
Est. $25.06B · +1.0%
Net income
$5.53B
As filed
EPS YoY
-0.9%
vs quarter ended 2025-06-30
Revenue YoY
+6.6%
vs quarter ended 2025-06-30
Next report
Oct 13, 2026
Scheduled · est. EPS $2.88
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$8.82
2026-03-29 through 2026-06-30
TTM revenue
$98.74B
2026-03-29 through 2026-06-30
Filed quarters
40
On record here
EPS at or above estimate (4Q)
0%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-06-30Q2 FY2026 | 2026-06-30 | $2.27 | $25.31B | -0.9% | +6.6% | $2.84 | -20.1% |
| 2026-06-28Q2 FY2026 | 2026-07-23 | $2.27 | $25.31B | -0.9% | +6.6% | $2.88 | -21.2% |
| 2026-03-31Q1 FY2026 | 2026-03-31 | $2.14 | $24.06B | -52.9% | +9.9% | $2.68 | -20.1% |
| 2026-03-29Q1 FY2026 | 2026-04-22 | $2.14 | $24.06B | -52.9% | +9.9% | $2.69 | -20.4% |
| 2025-12-31Q4 FY2025 | 2025-12-31 | $2.10 | $24.56B | +48.9% | +9.1% | $2.46 | -14.6% |
| 2025-12-28Q4 FY2025 | 2026-02-11 | $2.08 | $24.56B | +47.5% | +9.1% | — | — |
| 2025-09-28Q3 FY2025 | 2025-10-22 | $2.12 | $23.99B | +91.0% | +6.8% | $2.76 | -23.2% |
| 2025-06-30Q2 FY2025 | 2025-07-16 | $2.29 | $23.74B | +18.7% | +5.8% | $2.68 | -14.6% |
| 2025-06-29Q2 FY2025 | 2025-07-24 | $2.29 | $23.74B | +18.7% | +5.8% | — | — |
| 2025-03-30Q1 FY2025 | 2025-04-23 | $4.54 | $21.89B | +238.8% | +2.4% | $2.58 | +76.0% |
| 2024-12-29Q4 FY2024 | 2025-02-13 | $1.41 | $22.52B | -15.6% | +5.3% | $1.99 | -29.1% |
| 2024-09-29Q3 FY2024 | 2024-10-23 | $1.11 | $22.47B | -89.1% | +5.2% | $2.21 | -49.8% |
| 2024-06-30Q2 FY2024 | 2024-07-25 | $1.93 | $22.45B | -1.5% | +4.3% | $2.71 | -28.8% |
| 2024-03-31Q1 FY2024 | 2024-05-01 | $1.34 | $21.38B | +4566.7% | +2.3% | $2.64 | -49.2% |
| 2023-12-31Q4 FY2023 | 2024-02-16 | $1.67 | $21.39B | -5.6% | +119.0% | $2.27 | -26.4% |
| 2023-10-01Q3 FY2023 | 2023-10-27 | $10.21 | $21.35B | +645.3% | -8.5% | $2.52 | +305.2% |
| 2023-07-02Q2 FY2023 | 2023-07-31 | $1.96 | $21.52B | -16.6% | -7.7% | $2.61 | -24.9% |
| 2023-04-02Q1 FY2023 | 2023-04-28 | $-0.03 | $20.89B | -101.3% | -6.4% | $2.51 | -101.2% |
| 2023-01-01Q4 FY2023 | 2024-02-16 | $1.33 | $19.94B | -24.9% | +104.1% | $2.22 | -40.1% |
| 2022-10-02Q3 FY2023 | 2022-10-27 | $1.68 | $20.00B | +22.6% | -14.3% | $2.49 | -32.5% |
| 2022-07-03Q2 FY2023 | 2022-07-29 | $1.80 | $20.21B | -23.4% | -13.3% | $2.57 | -30.0% |
| 2022-04-03Q1 FY2023 | 2022-04-29 | $1.93 | $19.84B | -16.8% | -11.1% | $2.60 | -25.8% |
| 2022-01-02Q4 FY2022 | 2022-02-17 | $1.77 | $9.77B | +172.3% | -56.5% | $2.12 | -16.5% |
| 2021-10-03Q3 FY2022 | 2021-10-29 | $1.37 | $23.34B | +3.0% | +10.7% | $2.37 | -42.2% |
| 2021-07-04Q2 FY2022 | 2021-07-29 | $2.35 | $23.31B | +72.8% | +27.1% | $2.27 | +3.5% |
| 2021-04-04Q1 FY2022 | 2021-04-30 | $2.32 | $22.32B | +6.9% | +7.9% | $2.34 | -0.9% |
| 2021-01-03Q4 FY2021 | 2021-02-22 | $0.65 | $22.48B | -56.7% | +8.3% | $1.81 | -64.1% |
| 2020-09-27Q3 FY2021 | 2020-10-23 | $1.33 | $21.08B | +101.5% | +1.7% | $1.99 | -33.2% |
| 2020-06-28Q2 FY2021 | 2020-07-24 | $1.36 | $18.34B | -34.6% | -10.8% | $1.49 | -8.7% |
| 2020-03-29Q1 FY2021 | 2020-04-29 | $2.17 | $20.69B | +56.1% | +3.3% | $2.00 | +8.5% |
| 2019-12-29Q4 FY2019 | 2020-02-18 | $1.50 | $20.75B | +33.9% | +1.7% | $1.87 | -19.8% |
| 2019-09-29Q3 FY2019 | 2019-10-28 | $0.66 | $20.73B | -54.2% | +1.9% | $2.01 | -67.2% |
| 2019-06-30Q2 FY2019 | 2019-07-29 | $2.08 | $20.56B | +43.4% | -1.3% | $2.46 | -15.4% |
| 2019-03-31Q1 FY2019 | 2019-05-01 | $1.39 | $20.02B | -13.1% | +0.1% | $2.03 | -31.5% |
| 2018-12-30Q4 FY2018 | 2019-02-20 | $1.12 | $20.39B | +128.1% | +1.0% | $1.95 | -42.6% |
| 2018-09-30Q3 FY2018 | 2018-10-31 | $1.44 | $20.35B | +5.1% | +3.6% | $2.03 | -29.1% |
| 2018-07-01Q2 FY2018 | 2018-08-02 | $1.45 | $20.83B | — | — | $2.06 | -29.6% |
| 2018-04-01Q1 FY2018 | 2018-05-01 | $1.60 | $20.01B | — | — | $2.02 | -20.8% |
| 2017-12-31Q4 FY2017 | 2018-02-21 | $-3.99 | $20.20B | — | — | $1.72 | -332.0% |
| 2017-10-01Q3 FY2017 | 2017-11-02 | $1.37 | $19.65B | — | — | $1.80 | -23.9% |
Need JNJ data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.